Research Peptides UAE
Catalog by research category.
Five UAE-supplied categories. Every published batch links to a Janoshik Analytical Certificate of Analysis. ProPeptide categories show "Pending publication" until the lab report is released.
Triple-agonist (GLP-1/GIP/GCGR) research compound. Five formats: 30mg, 20mg, and 10mg pens plus 10mg and 40mg vials. Highest published Remy purity 99.841% HPLC.
- Retatrutide UAE overview →
- Retatrutide 30mg Pen
- Retatrutide 20mg Pen
- Retatrutide 10mg Vial
- From AED 340 · COA published
Body protective compound research line. 10mg lyophilised vials plus the BPC/TB combined blend. Repair-research category.
- BPC-157 10mg vial →
- TB-500 10mg vial
- BPC + TB combined blend
- All BPC / TB products
- From AED 250 · COA pending publication
Copper-binding tripeptide research compound. 50mg lyophilised vial format. Reconstitute with bacteriostatic water for in-vitro work.
- GHK-Cu 50mg vial →
- GHK-Cu research overview
- GLOW blend (GHK-Cu + BPC + TB)
- From AED 250 · COA pending publication
SS-31 (Elamipretide), Tesamorelin (GHRH analogue), AOD-9604, and the CJC-1295 + Ipamorelin blend. Lyophilised vial format.
- SS-31 10mg vial →
- Tesamorelin 10mg vial
- AOD-9604 10mg vial
- CJC-1295 + Ipamorelin blend
- From AED 250 · COA pending publication
Sterile reconstitution water for research workflows. 3ml vial with 0.9% benzyl alcohol preservative. Required for all lyophilised vial formats.
- BAC water 3ml vial →
- Reconstitution calculator
- How to read a Janoshik COA
- From AED 45 · sterile, single-use
21 research peptides plus blends. PT-141, KPV, MOTS-C, Semaglutide, Tirzepatide, and more. Browse the full product catalog.
All products →Janoshik-verified batches.
Public COAs.
Every published batch has a Janoshik Analytical report on the COA library. The Retatrutide 30mg Pen carries 99.262% HPLC (RETP002). The 20mg Pen carries 99.841% HPLC (RET-20-C-2604-001) — the highest published Remy purity. The 10mg / 40mg vial line (RET-20-V-2604-001, 99.741%) ships with a full sterility panel covering heavy metals, residual TFA, and bacterial endotoxin — a panel rarely published by other suppliers.
Some ProPeptide categories show "Pending publication" because the lab report has not yet been released. That is transparent disclosure, not a documentation gap — the batch ships with a paper certificate, the public PDF goes live once Janoshik returns it.
Dubai same-day. UAE next-day.
Research-use only. UAE compliance framing.
All Remy Peptides products are supplied strictly for in-vitro laboratory research. Per UAE MoHAP Circular 17/2022, peptides may not be marketed for therapeutic use without registration with the Ministry of Health and Prevention. Nothing on this page constitutes medical advice, diagnosis, treatment, or prevention.
Research peptide supply and peptide therapy are legally and operationally distinct in the UAE. Peptide therapy is a clinic-administered medical service offered by licensed practitioners under their own framework. Remy Peptides does not provide clinical services, does not administer compounds, and makes no human or veterinary claims.
Buyers are responsible for reviewing local regulations, handling requirements, and institutional research policies before procurement. Storage, reconstitution, and disposal must follow standard laboratory protocols.
Read the full regulatory breakdown at are peptides legal in Dubai? or the broader UAE peptide research overview.
Frequently Asked
Where can I buy research peptides in the UAE?
Are research peptides legal in the UAE?
Which Remy peptides have published COAs?
Do you deliver peptides to Abu Dhabi and Sharjah?
What is the difference between research peptides and peptide therapy?
How should peptides be stored in the UAE climate?
Start Your UAE Research Supply
For in-vitro laboratory research only. Not for human or veterinary use.